Kobayashi Kentaro, Hattori Naoya, Manabe Osamu, Hirata Kenji, Magota Keiichi, Shimamura Tsuyoshi, Tamaki Nagara
Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan.
Ann Transplant. 2015 Jan 26;20:51-8. doi: 10.12659/AOT.892490.
Living liver donation is associated with size-dependent complications. The resectable size and its safety margin should be defined for the safety of donors. The purpose of the present study was to determine if the current partial hepatectomies are done under the safety margin of the resectable size, by measuring asialoglycoprotein receptor (ASGPR) function of donor's remnant liver.
Seventy-four living donors (age 35±11 years) underwent Technetium-99m-diethylenetriaminepentaacetic acid-galactosyl-human serum albumin (Tc-99m GSA) scintigraphy at postoperative week 1. We evaluated the scintigraphic results using established parameters of GSA uptake (LHL15) and its clearance from the blood pool (HH15). Based on the literature, we consider HH15 <0.55 to indicate normal ASGPR function, and 0.55£ HH15 <0.65 to indicate mild impairment. In terms of the hepatic uptake, we consider LHL15>0.93 to indicate normal ASGPR function, and 0.87< LHL15 £0.93 to indicate mild impairment.
The average resected size was 337±170 mL, corresponding to 28±12% of the original donor's whole liver volume. No donors showed 0.65≤ HH15 or LHL15 <0.87, suggesting moderate or severely impaired ASGPR function. However, larger resection size (35-53%) was positively associated with higher HH15 values (R=0.53, p<0.001). In the range of HH15 (0.35-0.64) among present donors, higher HH15 values did not affect the regeneration volume (R=0.03, p=NS).
Larger partial resection (≥35% of the original liver volume) may impair postsurgical ASGPR function, but smaller resection (<35%) was considered to be under the safety margin of the hepatectomy. Although mildly impaired postsurgical ASGPR function did not indicate poor prognosis, careful attention may be required for donors undergoing larger (³35%) partial resection.
活体肝移植与大小相关的并发症有关。为了供体的安全,应确定可切除的肝脏大小及其安全 margins。本研究的目的是通过测量供体残余肝脏的去唾液酸糖蛋白受体(ASGPR)功能,来确定当前的部分肝切除术是否在可切除大小的安全 margins 范围内进行。
74 名活体供体(年龄 35±11 岁)在术后第 1 周接受了锝-99m-二乙三胺五乙酸-半乳糖基人血清白蛋白(Tc-99m GSA)闪烁扫描。我们使用既定的 GSA 摄取参数(LHL15)及其从血池清除的参数(HH15)来评估闪烁扫描结果。根据文献,我们认为 HH15<0.55 表示 ASGPR 功能正常,0.55≤HH15<0.65 表示轻度受损。就肝脏摄取而言,我们认为 LHL15>0.93 表示 ASGPR 功能正常,0.87<LHL15≤0.93 表示轻度受损。
平均切除大小为 337±170 mL,相当于原始供体全肝体积的 28±12%。没有供体显示 0.65≤HH15 或 LHL15<0.87,这表明 ASGPR 功能中度或严重受损。然而,更大的切除大小(35-53%)与更高的 HH15 值呈正相关(R=0.53,p<0.001)。在当前供体的 HH15 范围(0.35-0.64)内,较高的 HH15 值并未影响再生体积(R=0.03,p=无统计学意义)。
更大的部分切除术(≥原始肝脏体积的 35%)可能会损害术后 ASGPR 功能,但较小的切除术(<35%)被认为处于肝切除术的安全 margins 范围内。虽然术后 ASGPR 功能轻度受损并不表明预后不良,但对于接受较大(≥35%)部分切除术的供体可能需要密切关注。